Logo do repositório

Editorial: Epigenetic Therapy With Histone Deacetylase Inhibitors: Implications for Cancer Treatment

dc.contributor.authorSousa, Angela
dc.contributor.authorSoares, Christiane Pienna [UNESP]
dc.contributor.authorDos Santos, Jean Leandro [UNESP]
dc.contributor.institutionUniv Beira Interior
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2021-06-25T15:02:38Z
dc.date.available2021-06-25T15:02:38Z
dc.date.issued2021-04-06
dc.description.affiliationUniv Beira Interior, CICS UBI Hlth Sci Res Ctr, Covilha, Portugal
dc.description.affiliationSao Paulo State Univ, Sch Pharmaceut Sci, Clin Anal Dept, Araraquara, SP, Brazil
dc.description.affiliationSao Paulo State Univ, Sch Pharmaceut Sci, Drugs & Med Dept, Araraquara, SP, Brazil
dc.description.affiliationUnespSao Paulo State Univ, Sch Pharmaceut Sci, Clin Anal Dept, Araraquara, SP, Brazil
dc.description.affiliationUnespSao Paulo State Univ, Sch Pharmaceut Sci, Drugs & Med Dept, Araraquara, SP, Brazil
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipFEDER funds through the POCI-COMPETE 2020-Operational Programme Competitiveness and Internationalization in Axis I-Strengthening research, technological development and innovation
dc.description.sponsorshipFCT-Foundation for Science and Technology
dc.description.sponsorshipIdCAPES: 001
dc.description.sponsorshipIdFAPESP: 2018/11079-0
dc.description.sponsorshipIdCNPq: 304731/2017-0
dc.description.sponsorshipIdFEDER funds through the POCI-COMPETE 2020-Operational Programme Competitiveness and Internationalization in Axis I-Strengthening research, technological development and innovation: POCI-01-0145-FEDER-007491
dc.description.sponsorshipIdFCT-Foundation for Science and Technology: UID/Multi/00709/2019
dc.format.extent2
dc.identifierhttp://dx.doi.org/10.3389/fcell.2021.662761
dc.identifier.citationFrontiers In Cell And Developmental Biology. Lausanne: Frontiers Media Sa, v. 9, 2 p., 2021.
dc.identifier.doi10.3389/fcell.2021.662761
dc.identifier.issn2296-634X
dc.identifier.lattes1768025290373669
dc.identifier.orcid0000-0003-1740-7360
dc.identifier.urihttp://hdl.handle.net/11449/210247
dc.identifier.wosWOS:000641259200001
dc.language.isoeng
dc.publisherFrontiers Media Sa
dc.relation.ispartofFrontiers In Cell And Developmental Biology
dc.sourceWeb of Science
dc.subjectcancer treatment
dc.subjectcellular mechanisms
dc.subjectdrugs
dc.subjectepigenetics
dc.subjecthistone deacetylase inhibitors
dc.subjectmolecular biology
dc.titleEditorial: Epigenetic Therapy With Histone Deacetylase Inhibitors: Implications for Cancer Treatmenten
dc.typeEditorialpt
dcterms.rightsHolderFrontiers Media Sa
dspace.entity.typePublication
relation.isDepartmentOfPublicationa83d26d6-5383-42e4-bb3c-2678a6ddc144
relation.isDepartmentOfPublicatione214da1b-9929-4ae9-b8fd-655e9bfeda4b
relation.isDepartmentOfPublication.latestForDiscoverya83d26d6-5383-42e4-bb3c-2678a6ddc144
unesp.author.lattes1768025290373669[2]
unesp.author.orcid0000-0001-9155-7581[1]
unesp.author.orcid0000-0003-1740-7360[2]
unesp.departmentAnálises Clínicas - FCFpt
unesp.departmentFármacos e Medicamentos - FCFpt

Arquivos